Recalls & Warnings June 25, 2019 Kratom Is Dangerous and Not Proven to Treat Addiction, FDA Warns Marketers On June 25, 2019, the FDA issued warning letter to two marketers and distributors of kratom products, listed below, for illegally selling unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms
Candida Overgrowth: Real Concern or Overstated Problem
Thymosin Alpha-1's human data is far more extensive
Neuroprotective properties: Research suggests protective effects on the brain and nervous system, including potential benefits for dopaminergic and serotonergic systems
Protocol Details: Dose 1 mg Timing AM Frequency 5 days on, 2 days off Duration 8 weeks on, 8 weeks off Administration SubQ injection Source Jays Note: MOTS-C is unlike anything else in this stack it originates from within the mitochondria